Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $154.2900 (1.53%) ($150.1500 - $154.3500) on Thu. May. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.61% (three month average) | RSI | 48 | Latest Price | $154.2900(1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(39%) SPLV(30%) DIA(28%) VYM(27%) XLP(27%) | Factors Impacting ABBV price | ABBV will decline at least -0.805% in a week (0% probabilities). VIXM(-19%) UUP(-14%) TBT(-6%) UNG(0%) VXX(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.805% (StdDev 1.61%) | Hourly BBV | 0.7 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $152.43(1.22%) | 10 Day Moving Average | $151.14(2.08%) | 20 Day Moving Average | $154.08(0.14%) | To recent high | -11.8% | To recent low | 7.9% | Market Cap | $272.211b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |